Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

GENVAND.DK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3% 1.3%   Bankruptcy risk   8.4% 9.8% 12.5% 10.9% 18.5% 11.4% 16.0% 16.0%   Credit score (0-100)   30 25 17 21 7 21 12 12   Credit rating   BB BB BB BB B BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 -0.0 -0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   112 47.2 -58.5 199 -268 10.2 0.0 0.0   EBITDA   100 11.2 -85.3 176 -292 -15.9 0.0 0.0   EBIT   100 11.2 -85.3 176 -292 -15.9 0.0 0.0   Pre-tax profit (PTP)   97.2 11.0 -83.9 173.9 -292.7 -15.4 0.0 0.0   Net earnings   75.2 8.5 -66.6 134.2 -228.9 -79.2 0.0 0.0   Pre-tax profit without non-rec. items   97.2 11.0 -83.9 174 -293 -15.4 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   68.9 77.4 10.9 145 -83.8 -163 -243 -243   Interest-bearing liabilities   298 289 252 258 397 460 243 243   Balance sheet total (assets)   518 530 498 548 455 330 0.0 0.0   Net Debt   212 177 140 150 355 421 243 243     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   112 47.2 -58.5 199 -268 10.2 0.0 0.0   Gross profit growth   29.8% -57.9% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employees   1 0 1 1 1 1 0 0   Employee growth %   0.0% -100.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   518 530 498 548 455 330 0 0   Balance sheet change%   -38.5% 2.4% -6.1% 9.9% -17.0% -27.5% -100.0% 0.0%   Added value   100.2 11.2 -85.3 176.4 -292.3 -15.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 -1.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   89.3% 23.8% 145.7% 88.7% 109.0% -156.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   14.7% 2.3% -16.1% 33.8% -53.4% -3.1% 0.0% 0.0%   ROI %   28.5% 3.2% -26.3% 53.0% -72.5% -3.7% 0.0% 0.0%   ROE %   16.5% 11.7% -150.8% 172.1% -76.3% -20.2% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   13.3% 14.6% 2.2% 26.5% -15.6% -33.1% -100.0% -100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   211.4% 1,575.3% -164.6% 85.1% -121.4% -2,648.7% 0.0% 0.0%   Gearing %   432.0% 373.2% 2,321.4% 177.6% -473.5% -282.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.1% 0.3% 0.4% 1.1% 0.9% -0.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   0.5 0.5 0.5 0.4 0.2 0.1 0.0 0.0   Current Ratio   1.2 1.2 1.0 1.4 0.8 0.7 0.0 0.0   Cash and cash equivalent   85.8 112.3 111.9 107.6 41.8 38.1 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   68.9 77.4 10.9 145.1 -83.8 -163.0 -121.5 -121.5   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   100 0 -85 176 -292 -16 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   100 0 -85 176 -292 -16 0 0   EBIT / employee   100 0 -85 176 -292 -16 0 0   Net earnings / employee   75 0 -67 134 -229 -79 0 0